Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,943,179
+$6,917,257 QoQ
Shares Held
39,151
+216.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
#1,118
of 4,676 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Trek Financial, LLC holds $22,596,486 across 11 Drug Manufacturers - General names. JNJ ranks #1 (44.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
39,151 | $9,943,179 | |
| 2 | LLY |
ELI LILLY & Co
|
3,679 | $4,412,703 | |
| 3 | AMGN |
Amgen Inc
|
7,005 | $2,536,650 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
16,440 | $2,077,029 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,583 | $1,102,915 | |
| 6 | ABBV |
AbbVie Inc.
|
3,156 | $794,175 | |
| 7 | NVO |
Novo Nordisk A S
|
10,744 | $515,067 | |
| 8 | NVS |
Novartis AG
|
2,210 | $346,351 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,943,179 | 39,151 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,025,922 | 12,379 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,334,396 | 11,280 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $2,137,707 | 11,529 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $579,075 | 3,791 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $623,890 | 3,762 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $285,769 | 1,976 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $438,696 | 2,707 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $276,242 | 1,890 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $369,690 | 2,337 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $867,399 | 5,534 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $779,373 | 5,004 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $939,657 | 5,677 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,140,490 | 7,358 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $845,446 | 4,786 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $580,908 | 3,556 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,038,078 | 5,848 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $989,297 | 5,582 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $898,801 | 5,254 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $826,072 | 5,115 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $868,838 | 5,274 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $210,203 | 1,279 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $292,569 | 1,859 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $824,497 | 5,538 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $648,726 | 4,613 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||